Source: MedPage Today
By: Susman, Ed
Researchers at Brigham and Women’s Hospital and Harvard Medical School analyzed insurer databases and found that only 8.5 percent of people diagnosed with lupus, psoriatic arthritis, inflammatory bowel disease, and other autoimmune diseases had received at least one dose of the human papillomavirus (HPV) vaccine, versus 9.1 percent of people without autoimmune disease. Low uptake rates also were found among young girls and women, with only 13.1 percent of those with autoimmune disease and 14.1 percent of those without having received at least one of the three recommended doses. Fewer than 5 percent of young girls and women in both groups received all three doses of the HPV vaccine. Dr. Candace Feldman, rheumatology fellow at Brigham and Women’s Hospital and lead investigator, said: “While increased efforts are necessary for the entire population, a particular focus should be paid to those at high risk for persistent infection. Further studies are needed to better understand this low uptake and to determine strategies for improved access.” The study was presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals.